Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,811 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Author Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial.
Li R, Shah PH, Stewart TF, Nam JK, Bivalacqua TJ, Lamm DL, Uchio EM, Geynisman DM, Jacob JM, Meeks JJ, Dickstein R, Pearce SM, Kang SH, Jung SI, Kamat AM, Burke JM, Keegan KA, Steinberg GD. Li R, et al. Among authors: kang sh. Nat Med. 2024 Aug;30(8):2372. doi: 10.1038/s41591-024-03137-w. Nat Med. 2024. PMID: 38890533 No abstract available.
The Prognosis and Oncological Predictor of Urachal Carcinoma of the Bladder: A Large Scale Multicenter Cohort Study Analyzed 203 Patients With Long Term Follow-Up.
Yu YD, Ko YH, Kim JW, Jung SI, Kang SH, Park J, Seo HK, Kim HJ, Jeong BC, Kim TH, Choi SY, Nam JK, Ku JY, Joo KJ, Jang WS, Yoon YE, Yun SJ, Hong SH, Oh JJ. Yu YD, et al. Among authors: kang sh. Front Oncol. 2021 May 31;11:683190. doi: 10.3389/fonc.2021.683190. eCollection 2021. Front Oncol. 2021. PMID: 34136407 Free PMC article.
TNM-Based Head-to-Head Comparison of Urachal Carcinoma and Urothelial Bladder Cancer: Stage-Matched Analysis of a Large Multicenter National Cohort.
Song SH, Lee J, Ko YH, Kim JW, Jung SI, Kang SH, Park J, Seo HK, Kim HJ, Jeong BC, Kim TH, Choi SY, Nam JK, Ku JY, Joo KJ, Jang WS, Yoon YE, Yun SJ, Hong SH, Oh JJ. Song SH, et al. Among authors: kang sh. Cancer Res Treat. 2023 Oct;55(4):1337-1345. doi: 10.4143/crt.2023.417. Epub 2023 Apr 17. Cancer Res Treat. 2023. PMID: 37080605 Free PMC article.
Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial.
Li R, Shah PH, Stewart TF, Nam JK, Bivalacqua TJ, Lamm DL, Uchio EM, Geynisman DM, Jacob JM, Meeks JJ, Dickstein R, Pearce SM, Kang SH, Jung SI, Kamat AM, Burke JM, Keegan KA, Steinberg GD. Li R, et al. Among authors: kang sh. Nat Med. 2024 Aug;30(8):2216-2223. doi: 10.1038/s41591-024-03025-3. Epub 2024 Jun 6. Nat Med. 2024. PMID: 38844794 Clinical Trial.
Publisher Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial.
Li R, Shah PH, Stewart TF, Nam JK, Bivalacqua TJ, Lamm DL, Uchio EM, Geynisman DM, Jacob JM, Meeks JJ, Dickstein R, Pearce SM, Kang SH, Jung SI, Kamat AM, Burke JM, Keegan KA, Steinberg GD. Li R, et al. Among authors: kang sh. Nat Med. 2024 Aug;30(8):2377. doi: 10.1038/s41591-024-03157-6. Nat Med. 2024. PMID: 38956199 No abstract available.
Poor Preoperative Glycemic Control Is Associated with Dismal Prognosis after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Korean Multicenter Study.
Kang SG, Hwang EC, Jung SI, Yu HS, Chung HS, Kang TW, Kwon DD, Hwang JE, Kim JS, Noh JH, You JH, Kim MK, Oh TH, Seo IY, Baik S, Kim CS, Kang SH, Cheon J. Kang SG, et al. Among authors: kang sh, kang tw. Cancer Res Treat. 2016 Oct;48(4):1293-1301. doi: 10.4143/crt.2016.021. Epub 2016 Mar 23. Cancer Res Treat. 2016. PMID: 27034146 Free PMC article.
Is preoperative chronic kidney disease status associated with oncologic outcomes in upper urinary tract urothelial carcinoma? A multicenter propensity score-matched analysis.
Yu HS, Hwang JE, Chung HS, Cho YH, Kim MS, Hwang EC, Oh KJ, Kim SO, Jung SI, Kang TW, Kwon DD, Park K, Ryu SB, Jung SH, Hur YH, Noh JH, Kim MK, Seo IY, Kim CS, Kang SG, Kang SH, Cheon J. Yu HS, et al. Among authors: kang sh, kang tw, kang sg. Oncotarget. 2017 Mar 15;8(39):66540-66549. doi: 10.18632/oncotarget.16239. eCollection 2017 Sep 12. Oncotarget. 2017. PMID: 29029534 Free PMC article.
Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world setting.
Jung SI, Kim MS, Jeong CW, Kwak C, Hong SK, Kang SH, Joung JY, Lee SH, Yun SJ, Kim TH, Park SW, Jeon SS, Kang M, Lee JY, Chung BH, Hong JH, Ahn H, Kim CS, Kwon DD. Jung SI, et al. Among authors: kang sh, kang m. Investig Clin Urol. 2020 Jan;61(1):19-27. doi: 10.4111/icu.2020.61.1.19. Epub 2019 Dec 10. Investig Clin Urol. 2020. PMID: 31942459 Free PMC article.
Oncological outcome according to attainment of pentafecta after robot-assisted radical cystectomy in patients with bladder cancer included in the multicentre KORARC database.
Oh JJ, Lee S, Ku JH, Kwon TG, Kim TH, Jeon SH, Lee SH, Nam JK, Kim WS, Jeong BC, Lee JY, Hong SH, Rha KH, Han WK, Ham WS, Lee YG, Lee YS, Park SY, Yoon YE, Kang SG, Kang SH; Korean Robot Assisted Radical Cystectomy (KORARC) Study Group. Oh JJ, et al. Among authors: kang sh, kang sg. BJU Int. 2021 Feb;127(2):182-189. doi: 10.1111/bju.15178. Epub 2020 Aug 14. BJU Int. 2021. PMID: 32682331
2,811 results